Creating Production Standards in the CBD Industry

 

You may have noticed the surge of CBD products on shelves near you. Whether it’s at your local pharmacy, drug store, or even coffee shop, CBD is popping up everywhere in lotions, lattes, gummies, and oils. But how healthy is it, and what sort of quality and production standards are being set?

Here to answer our burning questions about this burgeoning industry on today’s Food & Beverage podcast is Kate Kinnison, vice president of sales and owner of RAD Extracts, a Colorado based B2B CBD supplier.

CBD (short for cannabidiol), is most commonly derived from the hemp plant. Hemp has gotten a bad rap because of its cousin, the marijuana plant, known to contain the psychoactive compound THC. But marijuana and hemp share another compound—CBD, which is completely legal and has shown positive health benefits in initial studies.

Kinnison explained how there’s more to CBD than just the compound itself. RAD Extracts looks at the hemp plant’s benefits holistically, utilizing all of hemp’s cannabinoids to create a product with the utmost benefit.

It comes down to, “All of those compounds in that plant working together in a synergistic feature, to really have the maximum benefits for individuals who are using it,” Kinnison said.

CBD is still rather unregulated, with no guarantee of the quality, purity, or efficacy of what’s hitting shelves. RAD Extracts aims to be ahead of the game, exercising the highest quality practices in their production to produce full-spectrum CBD, not a less-potent distillate.

“By creating a premium full spectrum product we really feel like we’re doing the plant justice,” Kinnison said.

So who could benefit from CBD?

“The amount of different applications it has is amazing,” Kinnison said, with some patients reporting it helping with conditions as varied as acute pain, chronic pain, epilepsy, anxiety, Alzheimers, and even acne.

The future of CBD is still unsure, but Kinnison projected that hemp’s popularity will increase as studies continue to come out touting the benefits of CBD.

For the latest news, videos, and podcasts in the Food & Beverage Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @FoodMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

GPU infrastructure
Amberd Moves to the Front of the Line With QumulusAI’s GPU Infrastructure
February 18, 2026

Reliable GPU infrastructure determines how quickly AI companies can execute. Teams developing private LLM platforms depend on consistent high-performance compute. Shared cloud environments often create delays when demand exceeds available capacity Mazda Marvasti, CEO of Amberd, says waiting for GPU capacity did not align with his company’s pace. Amberd required guaranteed availability to support…

Read More
private LLM
QumulusAI Secures Priority GPU Infrastructure Amid AWS Capacity Constraints on Private LLM Development
February 18, 2026

Developing a private large language model(LLM) on AWS can expose infrastructure constraints, particularly around GPU access. For smaller companies, securing consistent access to high-performance computing often proves difficult when competing with larger cloud customers. Mazda Marvasti, CEO of Amberd AI,  encountered these challenges while scaling his company’s AI platform. Because Amberd operates its own…

Read More
custom AI chips
Custom AI Chips Signal Segmentation for AI Teams, While NVIDIA Sets the Performance Ceiling for Cutting-Edge AI
February 18, 2026

Microsoft’s introduction of the Maia 200 adds to a growing list of hyperscaler-developed processors, alongside offerings from AWS and Google. These custom AI chips are largely designed to improve inference efficiency and optimize internal cost structures, though some platforms also support large-scale training. Google’s offering is currently the most mature, with a longer production…

Read More
GPUs
OpenAI–Cerebras Deal Signals Selective Inference Optimization, Not Replacement of GPUs
February 18, 2026

OpenAI’s partnership with Cerebras has raised questions about the future of GPUs in inference workloads. Cerebras uses a wafer-scale architecture that places an entire cluster onto a single silicon chip. This design reduces communication overhead and is built to improve latency and throughput for large-scale inference. Mark Jackson, Senior Product Manager at QumulusAI, says…

Read More